NCT07531459 Compilation and Preliminary Application of the Active Health Behavior Scale in Patients With Type 2 Diabetes
| NCT ID | NCT07531459 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Yun Ye |
| Condition | Type 2 Diabetes |
| Study Type | OBSERVATIONAL |
| Enrollment | 600 participants |
| Start Date | 2025-12-24 |
| Primary Completion | 2027-02-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 600 participants in total. It began in 2025-12-24 with a primary completion date of 2027-02-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to develop the Active Health Behavior Scale for Type 2 Diabetes Mellitus (T2DM) patients and evaluate its psychometric properties, including internal consistency reliability, test-retest reliability, content validity, construct validity, and criterion-related validity. Additionally, this research will investigate the current status of active health behaviors among T2DM patients and employ latent profile analysis (LPA) to identify distinct behavioral subtypes. Furthermore, differences in demographic, clinical, and psychosocial determinants across the identified latent classes will be examined to inform tailored intervention strategies.
Eligibility Criteria
Inclusion Criteria: * Patients with T2DM 1. Who have been diagnosed with T2DM and meet the diagnostic criteria defined by the Chinese Guideline for the Prevention and Treatment of Diabetes (2024 Edition); 2. Aged ≥18 years; 3. Who volunteer to participate in this study. Healthcare workers: 1. Clinicians and nurses who have been engaged in medical care in the endocrine field for ≥5 years; 2. Who hold a Bachelor's degree or above and have an intermediate or above professional title. Exclusion Criteria: * Patients with T2DM: 1. Who have acute complications of T2DM or other serious life-threatening diseases that preclude cooperation with the study; 2. Who have cognitive impairment or are unable to communicate in writing or verbally Healthcare workers: 1. Who do not have direct contact with patients; 2. Who are currently undergoing standardized training or refresher programs.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07531459 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Type 2 Diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07531459 currently recruiting?
Yes, NCT07531459 is actively recruiting participants. Contact the research team at ntyeyun@163.com for enrollment information.
Where is the NCT07531459 trial being conducted?
This trial is being conducted at Changzhou, China.
Who is sponsoring the NCT07531459 clinical trial?
NCT07531459 is sponsored by Yun Ye. The trial plans to enroll 600 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.